n-3 PUFAs

DIETARY_SUPPLEMENT4 trials

Sponsors

Northumbria University, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Università degli Studi di Brescia, Laval University

Conditions

Atrial FibrillationCognitive FunctionDilated CardiomyopathyHeart FailureMoodType 2 Diabetes

Phase 3

n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation

CompletedNCT01198275

Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaAtrial Fibrillation

Start: 2006-01-31End: 2008-05-31Updated: 2012-01-20

PUFAs and Left Ventricular Function in Heart Failure

CompletedNCT01223703

Università degli Studi di BresciaDilated Cardiomyopathy, Heart Failure

Start: 2007-11-30End: 2009-06-30Updated: 2012-01-31

Unknown Phase

Cognitive and Mood Effects of Docosahexaenoic Acid (DHA)-Rich and Eicosapentaenoic Acid (EPA)-Rich Fish Oil in Healthy Young Adults

CompletedNCT01075919

Northumbria UniversityCognitive Function, Mood

Start: 2007-12-31End: 2008-12-31Updated: 2010-02-25

Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes

CompletedNCT01449773

Laval UniversityType 2 Diabetes

Start: 2008-04-30End: 2013-01-31Updated: 2013-03-04

Related Papers

Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes

Nutrition Journal2013-07-1514 citations

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.

2011-08-1580 citations